| Literature DB >> 22005833 |
Ruidong Li1, Wenyuan Guo, Zhiren Fu, Guoshan Ding, You Zou, Zhengxin Wang.
Abstract
In the present study the capacity of Radix Paeoniae Rubra aqueous extract (RPRAE) as an antioxidant to protect against carbon tetrachloride (CCl(4))-induced oxidative stress and hepatotoxicity in Wistar rats was investigated. Six groups of rats were used. Radix Paeoniae Rubra aqueous extract (100 or 200 or 300 mg/kg of bw) or bifendate (100 mg/kg of bw) were given daily by gavage to the animals on 28 consecutive days to elucidate the protective effects against CCl(4)-induced hepatotoxicity. The 20% CCl(4)/olive oil was gavage of gastric tube twice a week (on the third and seventh days of each week). The animals of normal control group were given only vehicle. The animals of CCl(4)-treated group were administered with CCl(4) twice a week (on the third and seventh days of each week) and with vehicle on rest of the days. The test materials were found effective as hepatoprotective agents, as evidenced by plasma and liver biochemical parameters. Therefore, the results of this study show that Radix Paeoniae Rubra aqueous extract can protect the liver against CCl(4)-induced oxidative damage in rats, and the hepatoprotective effects might be correlated with its antioxidant and free radical scavenger effects.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22005833 PMCID: PMC6264168 DOI: 10.3390/molecules16108684
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Effect of aqueous extract of Radix Paeoniae Rubra on serum AST, ALT and ALP activities.
| Group | AST (U/L) | ALT (U/L) | ALP (U/L) |
|---|---|---|---|
| NC | 193.21 ± 12.65 | 39.75 ± 2.09 | 152.77 ± 10.65 |
| CCl4-treatment | 401.43 ± 29.85 b | 307.47 ± 19.65 b | 518.36 ± 36.27 b |
| CCl4+RPRAE (100 mg/kg b.w.) | 314.06 ± 22.14 d | 263.16 ± 13.61 c | 403.75 ± 33.32 d |
| CCl4+RPRAE (200 mg/kg b.w.) | 251.63 ± 15.07 d | 194.09 ± 13.69 d | 284.18 ± 14.09 d |
| CCl4+RPRAE (300 mg/kg b.w.) | 192.86 ± 12.54 d | 74.03 ± 4.53 d | 170.39 ± 12.57 d |
| CCl4+Bifendate (100 mg/kg b.w.) | 217.53 ± 15.06 d | 121.47 ± 8.64 d | 206.41 ± 18.54 d |
b P < 0.01, compared with NC group; c P < 0.05, d P < 0.01, compared with CCl4-treated group.
Note: NC (normal control).
Effect of aqueous extract of Radix Paeoniae Rubra on liver index and hydroxyproline levels.
| Group | Liver index | Hydroxyproline (μg·g−1) |
|---|---|---|
| NC | 3.15 ± 0.12 | 108.54 ± 8.54 |
| CCl4-treatment | 4.73 ± 0.24 b | 481.63 ± 23.11 b |
| CCl4+RPRAE (100 mg/kg b.w.) | 4.31 ± 0.25 c | 361.57 ± 23.07 d |
| CCl4+RPRAE (200 mg/kg b.w.) | 3.91 ± 0.19 d | 239.11 ± 16.74 d |
| CCl4+RPRAE (300 mg/kg b.w.) | 3.43 ± 0.12 d | 156.37 ± 12.14 d |
| CCl4+Bifendate (100 mg/kg b.w.) | 3.57 ± 0.19 d | 194.08 ± 18.62 d |
b P < 0.01, compared with NC group; c P < 0.05, d P < 0.01, compared with CCl4-treated group.
Note: NC (normal control).
Effect of aqueous extract of Radix Paeoniae Rubra on MDA and GSH levels and SOD, CAT, GSH-Px, TAOC activities.
| Group | TBARS (nmol MDA/mg Prot) | GSH (mg/g Prot) | SOD (U/mg prot) | CAT (U/mg prot) | GSH-Px (U/mg prot) | TAOC (U/mg prot) |
|---|---|---|---|---|---|---|
| NC | 234.42 ± 0.21 | 23.24 ± 1.33 | 363.14 ± 24.76 | 65.32 ± 0.43 | 52.11 ± 0.34 | 4.74 ± 0.32 |
| CCl4-treatment | 8.93 ± 0.65 b | 10.26 ± 1.07 b | 127.39 ± 10.54 b | 32.08 ± 0.14 b | 36.19 ± 0.22 b | 2.13 ± 0.12 b |
| CCl4+RPRAE (100 mg/kg b.w.) | 6.85 ± 0.35 d | 16.53 ± 1.25 d | 184.64 ± 13.29 d | 44.08 ± 0.25 d | 42.13 ± 0.27 c | 2.89 ± 0.19 c |
| CCl4+RPRAE (200 mg/kg b.w.) | 5.42 ± 0.24 d | 19.62 ± 1.66 d | 295.1 ± 21.64 d | 53.17 ± 0.31 d | 46.27 ± 0.21 d | 3.74 ± 0.14 d |
| CCl4+RPRAE (300 mg/kg b.w.) | 4.63 ± 0.3 d | 25.13 ± 1.72 d | 342.72 ± 22.54 d | 62.07 ± 0.36 d | 54.37 ± 0.33 d | 4.83 ± 0.31 d |
| CCl4+Bifendate (100 mg/kg b.w.) | 4.98 ± 0.37 d | 26.09 ± 2.01 d | 315.54 ± 25.01 d | 57.53 ± 0.4 d | 50.39 ± 0.38 d | 5.35 ± 0.29 d |
b P < 0.01, compared with NC group; c P < 0.05, d P < 0.01, compared with CCl4-treated group.
Note: NC (normal control).
Effect of aqueous extract of Radix Paeoniae Rubra on serum TP, Alb and G levels.
| Group | TP (mg/L) | Alb (mg/L) | G (mg/L) |
|---|---|---|---|
| NC | 88.32 ± 5.06 | 44.16 ± 2.08 | 35.16 ± 1.43 |
| CCl4-treatment | 42.07 ± 2.75 b | 30.15 ± 1.66 b | 13.65 ± 1.09 b |
| CCl4+RPRAE (100 mg/kg b.w.) | 69.35 ± 4.53 d | 37.12 ± 1.53 d | 22.41 ± 1.35 d |
| CCl4+RPRAE (200 mg/kg b.w.) | 74.62 ± 5.13 d | 43.62 ± 2.47 d | 28.94 ± 1.84 d |
| CCl4+RPRAE (300 mg/kg b.w.) | 86.01 ± 4.76 d | 50.49 ± 3.09 d | 34.27 ± 2.53 d |
| CCl4+Bifendate (100 mg/kg b.w.) | 71.54 ± 5.32 d | 47.53 ± 3.11 d | 32.61 ± 2.05 d |
b P < 0.01, compared with NC group; d P < 0.01, compared with CCl4-treated group.
Note: NC (normal control).